Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1226 - 1250 of 1564 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ▼ ChEBI ID Exact Mass Formula
Gangliosides LMSP0601AQ06
  • GD1b(d18:1/26:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262097 1949.097281 C92H164N4O39
Gangliosides LMSP0601AQ05
  • GD1b(d18:1/24:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262096 1921.065981 C90H160N4O39
Gangliosides LMSP0601AQ04
  • GD1b(d18:1/22:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262095 1893.034681 C88H156N4O39
Gangliosides LMSP0601AQ03
  • GD1b(d18:1/20:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262094 1865.003381 C86H152N4O39
Gangliosides LMSP0601AQ02
  • GD1b(d18:1/18:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262093 90238 1836.972081 C84H148N4O39
Gangliosides LMSP0601AQ01
  • GD1b(d18:1/16:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262092 1808.940781 C82H144N4O39
Gangliosides LMSP0601AP08
  • GM1(d18:1/26:1(17Z))
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262091 1655.986212 C81H145N3O31
Gangliosides LMSP0601AP07
  • GM1(d18:1/24:1(15Z))
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262090 84673 1627.954912 C79H141N3O31
Gangliosides LMSP0601AP06
  • GM1(d18:1/26:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262089 1658.001862 C81H147N3O31
Gangliosides LMSP0601AP05
  • GM1(d18:1/24:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262088 84671 1629.970562 C79H143N3O31
Gangliosides LMSP0601AP04
  • GM1(d18:1/22:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262087 1601.939262 C77H139N3O31
Gangliosides LMSP0601AP03
  • GM1(d18:1/20:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262086 1573.907962 C75H135N3O31
Gangliosides LMSP0601AP02
  • GM1(d18:1/18:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262085 61048 1545.876662 C73H131N3O31
Gangliosides LMSP0601AP01
  • GM1(d18:1/12:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/12:0)
44262084 1461.782762 C67H119N3O31
Gangliosides LMSP0601AO08
  • GT2(d18:1/26:1(17Z))
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262083 2076.124225 C97H169N5O42
Gangliosides LMSP0601AO07
  • GT2(d18:1/24:1(15Z))
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262082 2048.092925 C95H165N5O42
Gangliosides LMSP0601AO06
  • GT2(d18:1/26:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262081 2078.139875 C97H171N5O42
Gangliosides LMSP0601AO05
  • GT2(d18:1/24:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262080 2050.108575 C95H167N5O42
Gangliosides LMSP0601AO04
  • GT2(d18:1/22:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262079 2022.077275 C93H163N5O42
Gangliosides LMSP0601AO03
  • GT2(d18:1/20:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262078 1994.045975 C91H159N5O42
Gangliosides LMSP0601AO02
  • GT2(d18:1/18:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262077 84685 1966.014675 C89H155N5O42
Gangliosides LMSP0601AO01
  • GT2(d18:1/16:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262076 84653 1937.983375 C87H151N5O42
Gangliosides LMSP0601AN08
  • GD2(d18:1/26:1(17Z))
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262075 1785.028806 C86H152N4O34
Gangliosides LMSP0601AN07
  • GD2(d18:1/24:1(15Z))
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262074 1756.997506 C84H148N4O34
Gangliosides LMSP0601AN06
  • GD2(d18:1/26:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262073 1787.044456 C86H154N4O34

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024